[Edaily Reporter Shin Ha-yeon ] NextEye Co., Ltd.(137940)announced on the 31st that it recorded consolidated revenue of 119.4 billion won, operating profit of 3.2 billion won, and net income of 8.6 billion won for the first half of this year.
Revenue increased by 438.5% compared to the same period last year (22.2 billion won), and operating profit expanded from a profit of 90 million won in the same period last year. Net income rose by 107.9% year-over-year. These results were driven by the “ROADMIR” global B2C e-commerce platform business. Its U.S. subsidiary, ROADMIR Bio, recorded revenue of 114.3 billion won and operating profit of 4.7 billion won in the first half, with quarterly revenue also rising from 52.0 billion won in the first quarter to 62.3 billion won in the second quarter.
The company explained that stable sales of its anti-aging health supplement “IEONA GENEAKG” and the launch of new products contributed to the improved performance. ROADMIR operates a global cross-border e-commerce platform centered on China, Hong Kong, Taiwan, and Vietnam.
In contrast, the machine vision inspection equipment business posted an operating loss of 1.8 billion won in the first half. The company attributes this to a temporary revenue gap caused by major clients postponing their capital expenditure schedules to the second half and expects profitability to return to normal as order intake resumes in the second half.
NextEye Co., Ltd. plans to successively launch health functional foods featuring its proprietary composite blending technology, as well as new skincare and inner beauty products that differentiate themselves from existing offerings, in the second half of the year. The company explains that growth momentum is expected to strengthen further, given the seasonal trend of demand in the health functional food and cosmetics industries peaking in the second half of the year.
A company official stated, “Our half-year results have grown significantly just over a year after the full-scale launch of the Roadmir platform business,” adding, “We will continue this growth momentum in the second half of the year to further demonstrate our corporate value.”
The way global private equity fund (PEF) managers invest in rental housing is evolving. Previously, most cases involved directly purchasing individual properties. However, transactions have recently e…
SK hynix has drawn a clear line regarding reports that it is pursuing the sale of its stake in its Chongqing, China, plant, stating, “Nothing has been finalized.” This is the company’s response to a r…
Medy-Tox Inc.(086900)Medytox continued its revenue growth in the second quarter of this year, driven by expanded overseas sales of botulinum toxin and dermal fillers, as well as the successful market …